Adam Mueller completed his MD and PhD at the University of Virginia, his research work focusing primarily on non-coding RNA mediated regulation of gene expression in prostate and breast cancer, as well as in skeletal muscle development. He trained in radiation oncology at the University of Colorado Cancer Center, where he served as chief resident. His clinical practice includes advanced radiation oncology techniques such as SBRT, stereotactic radiosurgery, and brachytherapy, with a clinical interest in gastrointestinal, as well as head and neck malignancies. His post-doctoral research focused on resistance to radiation therapy in pancreatic cancer through modulation of the tumor stromal and immune microenvironment, and strategies to overcome this resistance by targeting the intersection of matrix metalloprotease ADAM10 with the EphB4-EphrinB2 tyrosine kinase receptor complex.
He has written clinical book chapters on proton therapy for prostate cancer, as well as SBRT for liver oligometastases. His work has resulted in over $170,000 of competitive external grant funding from the Deparment of Defense, Radiologic Society of North America, Cancer League of Colorado, and Paul Sandoval Foundation.
Adam has been the recipient of multiple awards, including the Joyce Hamlin award, UVA presidential fellowship, and Burgee Regents Scholarship. He is a member of the Arnold P Gold Humanism Society, the American Society of Radiation Oncology(ASTRO), the Radiologic Society of North America, the American Association for Cancer Research, as well as others. He lives in Denver, Colorado where he enjoys hiking 14ers, rock climbing and road biking.